Avalo Therapeutics, Inc. (AVTX) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Avalo Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.080 -- 00:00:04.543 Greetings and welcome to the Horizon Technology Finance Corporation fourth quarter 2023 00:00:04.543 -- 00:00:06.144 earnings 00:00:06.144 -- 00:00:11.107 call. At this time, all participants are in a listen-only mode. 00:00:11.107 -- 00:00:15.189 A question and answer session will follow the formal presentation. 00:00:15.189 -- 00:00:18.851 If anyone should require operator assistance during the conference, please press star 00:00:18.851 -- 00:00:21.553 zero on your telephone keypad. 00:00:21.553 -- 00:00:24.835 As a reminder, this conference is being recorded. 00:00:24.835 -- 00:00:29.994 I would now like to turn the conference over to your host, Megan Bacon, Director of IR. 00:00:29.994 -- 00:00:34.817 Thank you, and welcome to Horizon Technology Finance Corporation's fourth quarter 2023 00:00:34.817 -- 00:00:36.218 conference 00:00:36.218 -- 00:00:41.341 call. Representing the company today are Rob Pomeroy, Chairman and Chief Executive 00:00:41.341 -- 00:00:46.584 Officer, Jerry Michaud, President, Dan Dvoracic, Chief Operating 00:00:46.584 -- 00:00:52.409 Officer and Chief Investment Officer, and Dan Trollio, Chief Financial Officer. 00:00:52.409 -- 00:00:57.813 I would like to point out that the Q4 earnings press release and Form 10-K are available 00:00:57.813 -- 00:01:01.414 on the company's website at horizontechfinance.com. 00:01:02.136 -- 00:01:06.699 Before we begin our formal remarks, I need to remind everyone that during this conference 00:01:06.699 -- 00:01:11.463 call, the company will make certain forward-looking statements, including statements 00:01:11.463 -- 00:01:15.245 with regard to the future performance of the company. 00:01:15.245 -- 00:01:20.519 Words such as believe, expect, anticipate, Intense or simila...